| Name | Title | Contact Details |
|---|
Excellance Inc is a Madison, AL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Infusion Systems is a Valencia, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
OncoGenex is a biopharmaceutical company committed to the development and commercialization of new therapies that address treatment resistance in cancer patients. OncoGenex has a diverse oncology pipeline, with each product candidate having a distinct mechanism of action and representing a unique opportunity for cancer drug development. OncoGenex and Teva Pharmaceutical Industries Ltd. have entered a global collaboration and licensing agreement to develop and commercialize OncoGenex' lead drug candidate, custirsen. Custirsen is currently in Phase 3 clinical development as a treatment in men with metastatic castrate-resistant prostate cancer and in patients with advanced, unresectable non-small cell lung cancer. Apatorsen is in Phase 2 clinical development and OGX-225 is currently in pre-clinical development.
Nobis Rehabilitation Partners brings together hospitals, developers, and investment partners to develop, operate, and manage inpatient rehabilitation facilities (“IRFs”) throughout the United States. With vast experience developing IRFs across the country, the Nobis team has refined both the physical design and operational functionality of the hospital; ultimately streamlining outcomes and profitability.
Open Biosystems is a Huntsville, AL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.